James Investment Research’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-43,517
| Closed | -$322K | – | 645 |
|
|
2022
Q4 | $322K | Sell |
43,517
-565
| -1% | -$4.18K | 0.05% | 215 |
|
|
2022
Q3 | $436K | Hold |
44,082
| – | – | 0.06% | 186 |
|
|
2022
Q2 | $480K | Hold |
44,082
| – | – | 0.06% | 183 |
|
|
2022
Q1 | $499K | Hold |
44,082
| – | – | 0.05% | 201 |
|
|
2021
Q4 | $692K | Hold |
44,082
| – | – | 0.06% | 183 |
|
|
2021
Q3 | $756K | Hold |
44,082
| – | – | 0.07% | 171 |
|
|
2021
Q2 | $948K | Hold |
44,082
| – | – | 0.08% | 158 |
|
|
2021
Q1 | $662K | Buy |
44,082
+24,372
| +124% | +$366K | 0.06% | 180 |
|
|
2020
Q4 | $259K | Buy |
19,710
+25
| +0.1% | +$329 | 0.02% | 246 |
|
|
2020
Q3 | $190K | Hold |
19,685
| – | – | 0.02% | 257 |
|
|
2020
Q2 | $225K | Buy |
19,685
+1,505
| +8% | +$17.2K | 0.02% | 240 |
|
|
2020
Q1 | $188K | Buy |
+18,180
| New | +$188K | 0.02% | 234 |
|
|
2019
Q1 | – | Sell |
-41,400
| Closed | -$1.08M | – | 914 |
|
|
2018
Q4 | $1.08M | Buy |
+41,400
| New | +$1.08M | 0.07% | 290 |
|